Tervis
1059 instrumentiTervishoiusektoris tegutsevad ettevõtted
Eli Lilly$LLYHealth | 1,1 trln $ | 0,58% | 39,718 | 0,506 |
|---|---|---|---|---|
Johnson & Johnson$JNJHealth | 632 mld $ | 2,04% | 30,413 | 0,235 |
AbbVie$ABBVHealth | 442 mld $ | 2,76% | 70,721 | 0,28 |
UnitedHealth$UNHHealth | 355 mld $ | 2,35% | 25,469 | 0,632 |
Roche Holding€ROPHealth | 303 mld € | 0,00% | 23,079 | 0,344 |
Roche HoldingFr. ROPHealth | 284 mld CHF | 2,75% | 23,229 | 0,344 |
Merck & Co.$MRKHealth | 335 mld $ | 2,50% | 106,824 | 0,211 |
Novartis$NVSHealth | 289 mld $ | 2,03% | 22,974 | 0,495 |
Novartis AG€NOVNHealth | 250 mld € | 3,12% | 22,911 | 0,495 |
Novartis AGFr. NOVNHealth | 233 mld CHF | 3,03% | 22,718 | 0,495 |
AstraZeneca$AZNHealth | 243 mld $ | 2,77% | 23,487 | 0,225 |
AstraZeneca£AZNHealth | 179 mld £ | 2,05% | 23,391 | 0,225 |
Amgen$AMGNHealth | 227 mld $ | 2,40% | 26,057 | 0,413 |
Thermo Fisher Scientific$TMOHealth | 216 mld $ | 0,32% | 31,508 | 0,847 |
Novo NordiskDKr NOVO BHealth | 1,3 trln kr | 4,01% | 11,148 | 0,349 |
Novo Nordisk€NOVOBHealth | 173 mld € | 4,03% | 11,091 | 0,349 |
Novo Nordisk$NVOHealth | 200 mld $ | 3,89% | 11,071 | 0,349 |
Abbott$ABTHealth | 191 mld $ | 2,28% | 35,712 | 0,581 |
Gilead Sciences$GILDHealth | 172 mld $ | 2,36% | N/A | 0,336 |
Pfizer$PFEHealth | 153 mld $ | 6,40% | 35,361 | 0,28 |